Evidence map›Paper›PMID 25603283›Full record

ArticleBiological psychology2015

Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.

Rachel A Hay, Brian J Roach, Vinod H Srihari, Scott W Woods, Judith M Ford, Daniel H Mathalon

Registry-linked trialAbstract read
In one paragraph

Article in Biological psychology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02069925 (STEP-ED), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02069925 nacompletednot on this map

STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

TypeinterventionalSponsorYale UniversityRan2014 to 2020Enrolled285ConditionsPsychosis, SchizophreniaArmsEarly Detection (ED), Usual Detection
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2020
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rachel A HaySan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Brian J RoachSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Vinod H SrihariYale University School of Medicine, New Haven, CT, United States.
Scott W WoodsYale University School of Medicine, New Haven, CT, United States.
Judith M FordUniversity of California, San Francisco, CA, United States; San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.
Daniel H MathalonUniversity of California, San Francisco, CA, United States; San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States. Electronic address: daniel.mathalon@ucsf.edu.

Funding

Predictive Coding Abnormalities in Psychosis: EEG and fMRIR01MH058262 · NIMH · YALE UNIVERSITY · PI FORD, JUDITH M · 1998 to 2018
$6.4M
STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
9/9-Predictors and Mechanisms of Conversion to PsychosisU01MH076989 · NIMH · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MATHALON, DANIEL H · 2014 to 2018
$3.9M
Functional Brain Abnormalities in the Schizophrenia ProdromeR01MH076989 · NIMH · YALE UNIVERSITY · PI MATHALON, DANIEL H · 2007 to 2014
$2.3M
Rescuing the ruminating brain: Identifying biomarkers of rumination and mindfulness through concurrent EEG and fMRI studies of schizophrenia and depressionI01CX000497 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI Judith M Ford · 2011 to 2026
–
CSRD VA I01 CX000497NIMH NIH HHS MH058262NIMH NIH HHS MH076989NIMH NIH HHS R01 MH058262NIMH NIH HHS R01 MH076989NIMH NIH HHS R01 MH103831NIMH NIH HHS U01 MH076989
6 · The paper itself

Abstract

Neurophysiological abnormalities in auditory deviance processing, as reflected by the mismatch negativity (MMN), have been observed across the course of schizophrenia. Studies in early schizophrenia patients have typically shown varying degrees of MMN amplitude reduction for different deviant types, suggesting that different auditory deviants are uniquely processed and may be differentially affected by duration of illness. To explore this further, we examined the MMN response to 4 auditory deviants (duration, frequency, duration+frequency "double deviant", and intensity) in 24 schizophrenia-spectrum patients early in the illness (ESZ) and 21 healthy controls. ESZ showed significantly reduced MMN relative to healthy controls for all deviant types (p<0.05), with no significant interaction with deviant type. No correlations with clinical symptoms were present (all ps>0.05). These findings support the conclusion that neurophysiological mechanisms underlying processing of auditory deviants are compromised early in illness, and these deficiencies are not specific to the type of deviant presented.

Indexed as

AdolescentAdultBrainBrain MappingElectroencephalographyEvoked Potentials, AuditoryFemaleHumansMaleSchizophreniaYoung AdultAuditory cortexEvent-related potentialMismatch negativityMMNSchizophrenia-spectrum

Identifiers

PMID25603283
PMCPMC4336819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.